Nurse questionnaire for MS relapse monitoring
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at whether a nurse‑coordinated questionnaire can help monitor MS relapses. If you have relapsing-remitting or active secondary progressive MS and are followed by Dr. Manchon, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have relapsing-remitting MS or active secondary progressive MS
- You are under the care of Dr. Manchon for your MS
- You are not pregnant
- You do not have kidney failure
- You have agreed to be part of the local task-sharing program
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “subclinical markers,” meaning early or hidden body changes that may show how relapsing-remitting multiple sclerosis (MS) is doing even when symptoms seem mild. It may help researchers find better ways to monitor MS and detect changes sooner.
This study looks at how switching or failing multiple sclerosis (MS) treatments affects your feelings and daily life. It may help doctors better support people with relapsing-remitting MS.
This study looks at whether people with relapsing-remitting MS can experience symptom flare-ups (relapses) that don't show up on MRI scans. Researchers want to understand if this happens and what it means for your care.
This trial uses MRI scans to monitor spinal cord changes in people newly diagnosed with relapsing-remitting MS who have not yet started treatment. It aims to better understand how the disease progresses and could help guide early treatment decisions.
This study follows adults with relapsing-remitting multiple sclerosis using MRI scans and blood tests. It aims to understand how the disease behaves and what markers in blood and imaging may relate to changes over time.
This study tests different ways of monitoring people with relapsing-remitting MS who are reducing or stopping their medication. It aims to find the safest follow-up approach and may help guide future treatment decisions for those with stable disease.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.